SENATE-BILL 3345: S.3345 - PBM Price Transparency and Accountability Act
AI-Powered Summary
SENATE-BILL 3345 aims to enhance access to affordable prescription drugs for Medicare and Medicaid beneficiaries by regulating pharmacy benefit managers (PBMs) and pharmacies. The legislation focuses on ensuring fair compensation for pharmacies and promoting transparent pricing models, which are expected to lower out-of-pocket costs for individuals. Key provisions include the establishment of penalties for non-compliance by PBMs and pharmacies, thereby enforcing adherence to fair pricing practices. The bill addresses constitutional rights related to healthcare access and may invoke the Commerce Clause due to its regulation of interstate pharmaceutical activities. Implementation requirements involve compliance with new pricing transparency standards, although a specific timeline for these changes is not detailed. The potential impacts include improved access to necessary medications for low-income individuals and a reduction in discriminatory pricing practices, ultimately promoting equitable healthcare access.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill has significant implications for individuals' rights to access healthcare, particularly for vulnerable populations such as those on Medicaid and Medicare. By regulating pharmacy benefit managers and ensuring fair pricing practices, the legislation seeks to improve access to necessary medications, which is a critical aspect of healthcare rights.
Key Individual Rights Affected
- Right to Access Healthcare
- Equal Protection under the Law
- Due Process Rights
Constitutional Provisions
- 14th Amendment - Equal Protection Clause
- Constitutional commitment to promote general welfare
Potential Constitutional Challenges Or Support
Challenges
- Discrimination concerns if certain demographic groups face unequal access to medications.
- Due process concerns regarding the broad authority granted to the Secretary of Health and Human Services.
Support
- Promotion of general welfare through improved access to affordable medications.
- Increased transparency and accountability in drug pricing, aligning with principles of good governance.
Summary
SENATE-BILL 3345 aims to enhance access to affordable medications for individuals, particularly those in vulnerable demographic groups. While it supports constitutional principles by promoting healthcare access and transparency, it also raises important considerations regarding equal protection and potential disparities in implementation. The successful execution of the bill will require careful attention to these issues to ensure it fulfills its intended purpose without infringing on individual rights.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention S. 3345 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
December 4, 2025
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat